title: [Castration of prostate cancer patients and cognition].
authors.forename: Raija
authors.initials: R
authors.lastname: Portin
authors.forename: Aki
authors.initials: A
authors.lastname: Koskinen
authors.forename: Hans
authors.initials: H
authors.lastname: Helenius
authors.forename: Martti
authors.initials: M
authors.lastname: Nurmi
authors.forename: Eeva
authors.initials: E
authors.lastname: Salminen
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D002369:Castration / Q000379:methods; D003072:Cognition Disorders / Q000175:diagnosis / Q000209:etiology*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009483:Neuropsychological Tests; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D011944:Receptors, Androgen / Q000187:drug effects; D018570:Risk Assessment; D015996:Survival Rate; D013739:Testosterone / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D011944:Receptors, Androgen; D013739:Testosterone